|
|
Volumn 22, Issue 6, 2005, Pages 621-635
|
|
Postmarketing study of nateglinide in Japan: Treatment of medication-naïve patients with type 2 diabetes
|
|
Author keywords
Adverse effects; Clinical efficacy; Hypoglycemia; Nateglinide; NIDDM; Postmarketing surveillance study; Postprandial hyperglycemia; Type 2 diabetes
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
GLUCOSE;
HEMOGLOBIN A1C;
NATEGLINIDE;
ORAL ANTIDIABETIC AGENT;
VASODILATOR AGENT;
ABDOMINAL PAIN;
ADULT;
AGED;
ANEMIA;
ANOREXIA;
ARTICLE;
COLD SWEAT;
CONSTIPATION;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIARRHEA;
DIZZINESS;
DRUG EFFICACY;
DRUG MECHANISM;
FEMALE;
GLOSSITIS;
GLUCOSE BLOOD LEVEL;
HERPES ZOSTER;
HUMAN;
HYPERLIPIDEMIA;
HYPERURICEMIA;
HYPESTHESIA;
HYPOGLYCEMIA;
INFECTION;
JAPAN;
KIDNEY DYSFUNCTION;
LIVER DYSFUNCTION;
LOOSE FECES;
MAJOR CLINICAL STUDY;
MALE;
PERIPHERAL EDEMA;
PNEUMONIA;
POSTMARKETING SURVEILLANCE;
RASH;
STOMATITIS;
TINNITUS;
VOMITING;
ADULT;
AGED;
BLOOD GLUCOSE;
CYCLOHEXANES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
JAPAN;
MALE;
MIDDLE AGED;
PHENYLALANINE;
PRODUCT SURVEILLANCE, POSTMARKETING;
|
|
EID: 33645029685
PISSN: 0741238X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02849956 Document Type: Article |
|
Times cited : (3)
|
|
References (2)
|
